Sort
48,018 grants matching “immunotherapy”
Epigenetic control of Foxp3 expression in induced T regulatory cells
$450,000Anjana Rao · La Jolla Institute For Immunology · R01 · FY2020 · AI
Epigenetic control of Foxp3 expression in induced T regulatory cells
$450,000Anjana Rao · La Jolla Institute For Immunology · R01 · FY2017 · AI
Epigenetic control of Foxp3 expression in induced T regulatory cells
$450,000Anjana Rao · La Jolla Institute For Immunology · R01 · FY2019 · AI
Expanding the tumor antigen landscape and maintaining APCs in a T cell-activating state to restore tumor immunity
$449,997Eduardo Davila · University Of Colorado Denver · R01 · FY2024 · CA
B-CLL Biology: Impact of Combination Therapy
$449,968Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · CA
Rational in situ programming of cancer vaccine-responding T-cell clones
$449,968Matthias Stephan · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Humoral Immunity to vaccinia virus
$449,911Shane P Crotty · La Jolla Institute For Immunology · R01 · FY2007 · AI
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
$449,910Maninder Sandey · Auburn University At Auburn · R15 · FY2023 · CA
The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response
$449,825Melissa B Davis · Morehouse School Of Medicine · R01 · FY2024 · CA
Duke-UNC Chapel Hill Immunotherapy Training Grant
$449,807Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · T32 · FY2018 · CA
Targeting defective necroptosis in colorectal cancer
$449,762Lin Zhang · University Of Southern California · R01 · FY2023 · CA
Mechanisms by which effector T cells modulate endogenous remyelination
$449,740Peter A Calabresi · Johns Hopkins University · R37 · FY2017 · NS
Targeting autophagy to enhance immune checkpoint inhibition
$449,729Ravi K Amaravadi · Wistar Institute · P50 · FY2023 · CA
Modulation of tumor inflammatory factor for immune therapy
$449,561Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2019 · CA
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
$449,554Qing Yi · Methodist Hospital Research Institute · R01 · FY2024 · CA
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
$449,529Mark S Anderson · University Of California, San Francisco · R01 · FY2022 · DK
The differentiation and function of CD4+ Th2 cells during allergen-induced asthma
$449,500Marion Pepper · University Of Washington · R01 · FY2014 · AI
Novel Approaches to Targeting Cancers Associated with VHL Mutations
$449,476Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Ultrasensitive Env Detection Assay for Broadly Neutralizing Antibody Screening
$449,464Rebecca Marie Lynch · George Washington University · R61 · FY2024 · AI
Blocking NK cell shedding of CD16a to increase cancer cell killing
$449,369Bruce K Walcheck · University Of Minnesota · R01 · FY2020 · CA
Vaccine-based immunotherapy as an adjunct to drug treatment against NTM
$449,268Rhea N Coler · Seattle Children'S Hospital · R21 · FY2020 · AI
Microenvironmental Influences in Cancer
$449,242Jin Chen · Vanderbilt University · T32 · FY2022 · CA
DEVELOPMENTAL FUNDS
$449,226William L. Carroll · New York University School Of Medicine · P30 · FY2016 · CA
Targeting the PD-1H (VISTA) Pathway to Overcome Immunosuppression in Acute Myeloid Leukemia
$449,222Xue Han · Ohio State University · R37 · FY2025 · CA
Intrapleural immunotherapeutic nanoparticles for MPE treatment
$449,180Dawen Zhao · Wake Forest University Health Sciences · R01 · FY2023 · CA